Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

HEPARIN FOR PHYSICO- CHEMICALANALYSIS CRS (300 MG)

HEPARIN FOR PHYSICO- CHEMICALANALYSIS CRS (300 MG)

01/08/9041

DISCOVER
HEPARIN SODIUM FOR NMR IDENTIFICATION CRS (50 MG)

HEPARIN SODIUM FOR NMR IDENTIFICATION CRS (50 MG)

01/08/9041

DISCOVER
LUFENURON CRS (140 MG)

LUFENURON CRS (140 MG)

103055-07-8

DISCOVER
SERTRALINE IMPURITY E CRS (20MG)

SERTRALINE IMPURITY E CRS (20MG)

611-71-2

DISCOVER
ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE CRS (110 MG)

ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE CRS (110 MG)

138982-67-9

DISCOVER
HEPARIN CALCIUM FOR NMR IDENTIFICATION CRS (30 MG)

HEPARIN CALCIUM FOR NMR IDENTIFICATION CRS (30 MG)

37270-89-6

DISCOVER
Salbutamol sulfate for systemsuitability CRS, 50mg

Salbutamol sulfate for systemsuitability CRS, 50mg

51022-70-9

DISCOVER
MAGNOLOL CRS (20 MG)

MAGNOLOL CRS (20 MG)

528-43-8

DISCOVER
HONOKIOL CRS (20 MG)

HONOKIOL CRS (20 MG)

35354-74-6

DISCOVER
IODIXANOL IMPURITY E CRS (10.025 MG)

IODIXANOL IMPURITY E CRS (10.025 MG)

NA

DISCOVER
IODIXANOL IMPURITY C CRS (10 MG)

IODIXANOL IMPURITY C CRS (10 MG)

NA

DISCOVER
IODIXANOL IMPURITY H CRS (10 MG)

IODIXANOL IMPURITY H CRS (10 MG)

NA

DISCOVER